Literature DB >> 26202927

Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing.

N Cervera1, N Carbuccia1, S Garnier1, A Guille1, J Adélaïde1, A Murati1,2, N Vey3,4, M-J Mozziconacci1,2, M Chaffanet1,3, D Birnbaum1,3, V Gelsi-Boyer1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26202927     DOI： 10.1038/leu.2015.198

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase.

Authors:  Mandy Brecqueville; Jérôme Rey; Raynier Devillier; Arnaud Guille; Rémi Gillet; José Adélaide; Véronique Gelsi-Boyer; Christine Arnoulet; Max Chaffanet; Marie-Joelle Mozziconacci; Norbert Vey; Daniel Birnbaum; Anne Murati
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

2.  Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

Authors:  Ulrike Bacher; Claudia Haferlach; Tamara Alpermann; Wolfgang Kern; Susanne Schnittger; Torsten Haferlach
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

3.  Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Authors:  R Coleman Lindsley; Brenton G Mar; Emanuele Mazzola; Peter V Grauman; Sarah Shareef; Steven L Allen; Arnaud Pigneux; Meir Wetzler; Robert K Stuart; Harry P Erba; Lloyd E Damon; Bayard L Powell; Neal Lindeman; David P Steensma; Martha Wadleigh; Daniel J DeAngelo; Donna Neuberg; Richard M Stone; Benjamin L Ebert
Journal:  Blood       Date:  2014-12-30       Impact factor: 22.113

4.  Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.

Authors:  Chi Young Ok; Keyur P Patel; Guillermo Garcia-Manero; Mark J Routbort; Bin Fu; Guilin Tang; Maitrayee Goswami; Rajesh Singh; Rashmi Kanagal-Shamanna; Sherry A Pierce; Ken H Young; Hagop M Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Sa A Wang
Journal:  Leuk Res       Date:  2014-12-20       Impact factor: 3.156

Review 5.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

6.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

7.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

8.  Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling.

Authors:  Erdogan Taskesen; Marije Havermans; Kirsten van Lom; Mathijs A Sanders; Yvette van Norden; Eric Bindels; Remco Hoogenboezem; Marcel J T Reinders; Maria E Figueroa; Peter J M Valk; Bob Löwenberg; Ari Melnick; Ruud Delwel
Journal:  Blood       Date:  2014-03-25       Impact factor: 22.113

9.  Integrated profiling of basal and luminal breast cancers.

Authors:  José Adélaïde; Pascal Finetti; Ismahane Bekhouche; Laetitia Repellini; Jeannine Geneix; Fabrice Sircoulomb; Emmanuelle Charafe-Jauffret; Nathalie Cervera; Jérôme Desplans; Daniel Parzy; Eric Schoenmakers; Patrice Viens; Jocelyne Jacquemier; Daniel Birnbaum; François Bertucci; Max Chaffanet
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

10.  Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.

Authors:  Y Collette; T Prébet; A Goubard; J Adélaïde; R Castellano; N Carbuccia; S Garnier; A Guille; C Arnoulet; A Charbonier; M J Mozziconacci; D Birnbaum; M Chaffanet; N Vey
Journal:  Blood Cancer J       Date:  2015-03-13       Impact factor: 11.037
View more
  13 in total

1.  The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile?

Authors:  Margot F van Spronsen; Theresia M Westers; Birgit I Lissenberg-Witte; Mariëlle Wondergem; Gert J Ossenkoppele; Arjan A van de Loosdrecht
Journal:  Haematologica       Date:  2019-04-19       Impact factor: 9.941

2.  Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Authors:  Ilaria Iacobucci; Ji Wen; Manja Meggendorfer; John K Choi; Lei Shi; Stanley B Pounds; Catherine L Carmichael; Katherine E Masih; Sarah M Morris; R Coleman Lindsley; Laura J Janke; Thomas B Alexander; Guangchun Song; Chunxu Qu; Yongjin Li; Debbie Payne-Turner; Daisuke Tomizawa; Nobutaka Kiyokawa; Marcus Valentine; Virginia Valentine; Giuseppe Basso; Franco Locatelli; Eric J Enemark; Shirley K Y Kham; Allen E J Yeoh; Xiaotu Ma; Xin Zhou; Edgar Sioson; Michael Rusch; Rhonda E Ries; Elliot Stieglitz; Stephen P Hunger; Andrew H Wei; L Bik To; Ian D Lewis; Richard J D'Andrea; Benjamin T Kile; Anna L Brown; Hamish S Scott; Christopher N Hahn; Paula Marlton; Deqing Pei; Cheng Cheng; Mignon L Loh; Benjamin L Ebert; Soheil Meshinchi; Torsten Haferlach; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

3.  The ParaHox gene Cdx4 induces acute erythroid leukemia in mice.

Authors:  Silvia Thoene; Tamoghna Mandal; Naidu M Vegi; Leticia Quintanilla-Martinez; Reinhild Rösler; Sebastian Wiese; Klaus H Metzeler; Tobias Herold; Torsten Haferlach; Konstanze Döhner; Hartmut Döhner; Luisa Schwarzmüller; Ursula Klingmüller; Christian Buske; Vijay P S Rawat; Michaela Feuring-Buske
Journal:  Blood Adv       Date:  2019-11-26

4.  Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.

Authors:  Nathalie Cervera; Anne-Catherine Lhoumeau; José Adélaïde; Arnaud Guille; Anne Murati; Marie-Joëlle Mozziconacci; Norbert Vey; Daniel Birnbaum; Véronique Gelsi-Boyer
Journal:  Haematologica       Date:  2019-10-10       Impact factor: 9.941

5.  De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.

Authors:  Erica F Reinig; Patricia T Greipp; April Chiu; Matthew T Howard; Kaaren K Reichard
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

Review 6.  Erythroid Cell Research: 3D Chromatin, Transcription Factors and Beyond.

Authors:  Charlotte Andrieu-Soler; Eric Soler
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

Review 7.  Erythroleukemia-historical perspectives and recent advances in diagnosis and management.

Authors:  Prajwal Boddu; Christopher B Benton; Wei Wang; Gautam Borthakur; Joseph D Khoury; Naveen Pemmaraju
Journal:  Blood Rev       Date:  2017-09-18       Impact factor: 8.250

8.  Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia.

Authors:  N Ping; A Sun; Y Song; Q Wang; J Yin; W Cheng; Y Xu; L Wen; H Yao; L Ma; H Qiu; C Ruan; D Wu; S Chen
Journal:  Leukemia       Date:  2016-06-15       Impact factor: 11.528

9.  Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

Authors:  Alexandre Fagnan; Frederik Otzen Bagger; Maria-Riera Piqué-Borràs; Cathy Ignacimouttou; Alexis Caulier; Cécile K Lopez; Elie Robert; Benjamin Uzan; Véronique Gelsi-Boyer; Zakia Aid; Cécile Thirant; Ute Moll; Samantha Tauchmann; Amina Kurtovic-Kozaric; Jaroslaw Maciejewski; Christine Dierks; Orietta Spinelli; Silvia Salmoiraghi; Thomas Pabst; Kazuya Shimoda; Virginie Deleuze; Hélène Lapillonne; Connor Sweeney; Véronique De Mas; Betty Leite; Zahra Kadri; Sébastien Malinge; Stéphane de Botton; Jean-Baptiste Micol; Benjamin Kile; Catherine L Carmichael; Ilaria Iacobucci; Charles G Mullighan; Martin Carroll; Peter Valent; Olivier A Bernard; Eric Delabesse; Paresh Vyas; Daniel Birnbaum; Eduardo Anguita; Loïc Garçon; Eric Soler; Juerg Schwaller; Thomas Mercher
Journal:  Blood       Date:  2020-08-06       Impact factor: 25.476

10.  Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.

Authors:  Paolo Sportoletti; Daniele Sorcini; Anna G Guzman; Jaime M Reyes; Arianna Stella; Andrea Marra; Sara Sartori; Lorenzo Brunetti; Roberta Rossi; Beatrice Del Papa; Francesco Maria Adamo; Giulia Pianigiani; Camilla Betti; Annarita Scialdone; Valerio Guarente; Giulio Spinozzi; Valentina Tini; Maria Paola Martelli; Margaret A Goodell; Brunangelo Falini
Journal:  Leukemia       Date:  2020-11-06       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.